Does HER2/neu Overexpression in Breast Cancer Influence Adjuvant Chemotherapy and Hormonal Therapy Choices by Ontario Physicians? A Physician Survey
Excerpt
The HER2 gene (formerly called c-erbB-2) encodes a 185-kDa transmembrane glycoprotein with intracellular tyrosine kinase activity. [...]
Share and Cite
Myers, J.A.; DeBoer, G.; Warner, E. Does HER2/neu Overexpression in Breast Cancer Influence Adjuvant Chemotherapy and Hormonal Therapy Choices by Ontario Physicians? A Physician Survey. Curr. Oncol. 2006, 13, 2-7. https://doi.org/10.3390/curroncol13010001
Myers JA, DeBoer G, Warner E. Does HER2/neu Overexpression in Breast Cancer Influence Adjuvant Chemotherapy and Hormonal Therapy Choices by Ontario Physicians? A Physician Survey. Current Oncology. 2006; 13(1):2-7. https://doi.org/10.3390/curroncol13010001
Chicago/Turabian StyleMyers, J.A., G. DeBoer, and E. Warner. 2006. "Does HER2/neu Overexpression in Breast Cancer Influence Adjuvant Chemotherapy and Hormonal Therapy Choices by Ontario Physicians? A Physician Survey" Current Oncology 13, no. 1: 2-7. https://doi.org/10.3390/curroncol13010001
APA StyleMyers, J. A., DeBoer, G., & Warner, E. (2006). Does HER2/neu Overexpression in Breast Cancer Influence Adjuvant Chemotherapy and Hormonal Therapy Choices by Ontario Physicians? A Physician Survey. Current Oncology, 13(1), 2-7. https://doi.org/10.3390/curroncol13010001